Pancreatic cancer is fueled by connections to the nervous system. This is reported by scientists from the German Cancer ...

titled Intercellular TIMP-1-CD63 signalling directs the evolution of immune escape and metastasis in KRAS-mutated pancreatic cancer cells, was based on laboratory experiments using mice ...

An investigational therapy significantly shrank lung cancer tumors that are notoriously resistant to treatment by encouraging ...

Aug. 28, 2024 — Researchers have demonstrated in mice a new method to combat pancreatic cancer. The study outlines the synergistic effects of a novel nanoparticle drug-delivery system to ...

Basal cell carcinomas (BCCs) are keratinocyte tumours that resemble the basal layer of the epidermis, and are the most commonly diagnosed human cancer among ... carcinomas in situ, some get ...

Background PARP inhibitors (PARPi) have been licensed for the maintenance therapy of patients with metastatic pancreatic cancer carrying pathogenic germline ... reporter system, in situ proximity ...

After surgical resection of PDA, the nucleoside analogue gemcitabine was widely used as standard adjuvant treatment based on results from the European Study Group for Pancreatic Cancer-3 (ESPAC ...

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study published in the journal Nature.

Scientists have developed a new mRNA vaccine to treat pancreatic cancer that may extend patients' lifespans by 8 to 10 years.